PlainRecalls
FDA Devices Moderate Class II Ongoing

Simplexa COVID-19 Direct, REF: MOL4150; including Reaction Mix, REF: MOL4150; with previous assay definition v2

Reported: March 15, 2023 Initiated: January 30, 2023 #Z-1209-2023

Product Description

Simplexa COVID-19 Direct, REF: MOL4150; including Reaction Mix, REF: MOL4150; with previous assay definition v2

Reason for Recall

Direct amplification Discs , used with COVID-19 and Flu A/B & RSV assays, may leak and cause contamination, cross-contamination, invalid results, and error codes.

Details

Recalling Firm
DiaSorin Molecular LLC
Units Affected
90142
Distribution
US Nationwide distribution including in the states of NJ, ME, ND, IL, MI, FL, GA, AZ, MA, CA, MO, SD, MN, PA, OH, VT, NE, WI, CO, DC, VA, TX, NH, IN, IA, MD, NC, AL, NY, KY, WV, RI, KS, NM, OK, WA, SC, CT, TN, NV, LA.
Location
Cypress, CA

Frequently Asked Questions

What product was recalled?
Simplexa COVID-19 Direct, REF: MOL4150; including Reaction Mix, REF: MOL4150; with previous assay definition v2. Recalled by DiaSorin Molecular LLC. Units affected: 90142.
Why was this product recalled?
Direct amplification Discs , used with COVID-19 and Flu A/B & RSV assays, may leak and cause contamination, cross-contamination, invalid results, and error codes.
Which agency issued this recall?
This recall was issued by the FDA Devices on March 15, 2023. Severity: Moderate. Recall number: Z-1209-2023.